Exchange of alkali trace elements in hemodialysis Patients: a comparison with Na(+) and K(+).
BACKGROUND
In the past, nephrologists have been troubled by electrolyte disturbances and consequently focused their attention on the importance of maintaining the concentrations of electrolytes within the normal range. However, information about the potential role of trace elements in chronic renal failure is scarce.


METHODS
During hemodialysis sessions, the concentrations of the five alkali metal cations lithium (Li), sodium (Na), potassium (K), rubidium (Rb), and cesium (Cs) have been determined in plasma and dialysis fluids of chronic hemodialysis patients by inductively coupled plasma mass spectrometry (Li, Rb, Cs) and by ion-sensitive electrodes (Na, K). Strict quality control schemes were applied to all analytical procedures to ensure accuracy and precision of the results.


RESULTS
The plasma concentrations of the elements Li, Cs, Rb, and K distinctly decreased to 29, 50, 69, and 71%, respectively, of their initial values during hemodialysis. Simultaneously, the concentrations of these elements in dialysis fluids at the outlet of the dialyzer increased approximately 13-fold for Rb, 11-fold for Li, 3-fold for Cs, and 2-fold for K as compared with the inlet values. The concentrations of Na in plasma and dialysis fluids were almost identical and did not change during hemodialysis.


CONCLUSIONS
Li, Rb, and Cs were depleted in hemodialysis patients, although the plasma concentrations of these trace elements still remained within the reference ranges for healthy adults. Consequently, further studies are needed to elucidate the clinical importance and long-term effects of these trace element imbalances - for example, CNS disturbances associated with diminished concentrations of Rb - in hemodialysis patients.
Krachler
M
M
Institute of Analytical Chemistry, Medical School, Karl Franzens University, Graz, Austria.
Scharfetter
H
H
Wirnsberger
G H
GH
D000328:Adult; D000368:Aged; D002586:Cesium / Q000032:analysis / Q000097:blood; D002624:Chemistry, Clinical / Q000592:standards; D015314:Dialysis Solutions / Q000008:administration & dosage / Q000737:chemistry; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy*; D008094:Lithium / Q000032:analysis / Q000097:blood; D008297:Male; D008672:Metals, Alkali / Q000032:analysis / Q000097:blood*; D008875:Middle Aged; D011188:Potassium / Q000032:analysis / Q000097:blood*; D011786:Quality Control; D006435:Renal Dialysis; D012413:Rubidium / Q000032:analysis / Q000097:blood; D012964:Sodium / Q000032:analysis / Q000097:blood*
D015314:Dialysis Solutions; D008672:Metals, Alkali; D002586:Cesium; D008094:Lithium; D012964:Sodium; D012413:Rubidium; D011188:Potassium